COYANasdaqPharmaceutical PreparationsFiscal year ends December 31
Coya Therapeutics, Inc.
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 11, 2026
$4.20−0.05 (-1.18%)
Close on Oct 19, 2026
- Market cap
- $98.52M
- P/E (TTM)
- –
- Dividend yield
- –
SEC filings
40 of Coya Therapeutics's most recent filings on SEC EDGAR
| Document | Form | Period | Filed | Source |
|---|---|---|---|---|
| Current report | 8-K | Oct 14, 2026 | Oct 14, 2026 | SEC EDGAR |
| Current report | 8-K | Oct 5, 2026 | Oct 5, 2026 | SEC EDGAR |
| Current report | 8-K | Sep 15, 2026 | Sep 15, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Aug 11, 2026 | Aug 11, 2026 | SEC EDGAR |
| Current report | 8-K | Jun 25, 2026 | Jun 25, 2026 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 25, 2026 | May 13, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | May 12, 2026 | May 12, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 29, 2026 | Apr 2, 2026 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2025 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Mar 16, 2026 | Mar 16, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 29, 2026 | Jan 30, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 20, 2026 | Jan 20, 2026 | SEC EDGAR |
| Current report | 8-K | Jan 8, 2026 | Jan 8, 2026 | SEC EDGAR |
| Current report | 8-K | Dec 16, 2025 | Dec 17, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Nov 12, 2025 | Nov 12, 2025 | SEC EDGAR |
| Current report | 8-K | Oct 23, 2025 | Oct 27, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 29, 2025 | Sep 2, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Aug 12, 2025 | Aug 12, 2025 | SEC EDGAR |
| Current report | 8-K | Jul 29, 2025 | Jul 29, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 30, 2025 | Jul 1, 2025 | SEC EDGAR |
| Current report | 8-K | Jun 26, 2025 | Jun 26, 2025 | SEC EDGAR |
| Proxy statement | DEF 14A | Jun 26, 2025 | May 16, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Mar 31, 2025 | May 13, 2025 | SEC EDGAR |
| Current report | 8-K | May 13, 2025 | May 13, 2025 | SEC EDGAR |
| Annual report, amended | 10-K/A | Dec 31, 2024 | Apr 28, 2025 | SEC EDGAR |
| Annual report | 10-K | Dec 31, 2024 | Mar 18, 2025 | SEC EDGAR |
| Current report | 8-K | Mar 18, 2025 | Mar 18, 2025 | SEC EDGAR |
| Quarterly report | 10-Q | Sep 30, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 6, 2024 | Nov 6, 2024 | SEC EDGAR |
| Current report | 8-K | Nov 1, 2024 | Nov 5, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 28, 2024 | Oct 31, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 29, 2024 | Oct 29, 2024 | SEC EDGAR |
| Current report | 8-K | Oct 21, 2024 | Oct 22, 2024 | SEC EDGAR |
| Current report | 8-K | Aug 16, 2024 | Aug 19, 2024 | SEC EDGAR |
| Quarterly report | 10-Q | Jun 30, 2024 | Aug 12, 2024 | SEC EDGAR |